# EULAT Eradicate GBC

> **NCT06192719** · — · RECRUITING · sponsor: **Centre Paul Strauss** · enrollment: 15000 (estimated)

## Conditions studied

- Gallbladder Cancer
- Gallstone Disease

## Interventions

- **OTHER:** None, observational study.

## Key facts

- **NCT ID:** NCT06192719
- **Lead sponsor:** Centre Paul Strauss
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-12-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 15000 (ESTIMATED)
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06192719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06192719, "EULAT Eradicate GBC". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06192719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*